Skip Navigation


European Heart Journal Advance Access originally published online on November 5, 2007
European Heart Journal 2007 28(24):2960-2961; doi:10.1093/eurheartj/ehl399
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/24/2960    most recent
ehl399v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van Kimmenade, R. R.J.
Right arrow Articles by Januzzi, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Kimmenade, R. R.J.
Right arrow Articles by Januzzi, J. L., Jr
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For permissions please email: journals.permissions@oxfordjournals.org

When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the ‘cardio-renal syndrome’?

Roland R.J. van Kimmenade1, Yigal Pinto1 and James L. Januzzi, Jr2,*

1 Department of Cardiology, University Hospital Maastricht, The Netherlands
2 Division of Cardiology, Massachusetts General Hospital, Yawkey 5800, 55 Fruit Street, Boston, MA 02114, USA

* Corresponding author. Tel: +1 617 726 3443; fax: +1 617 643 1620. E-mail address: jjanuzzi@partners.org

Footnotes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology. Back

The first 10% of the full text of this article appears below.

This editorial refers to ‘Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure’ by R.S. Gardner et al., on page 3027

Gardner et al.,1 report that NT-proBNP maintains strong prognosis in heart failure (HF) patients with renal impairment. This is an interesting contribution to the debate about the utility of NT-proBNP in renal impairment; chronic kidney disease is an important complication in patients suffering from HF, while there is often heated discussion about the usefulness of BNP and NT-proBNP measurement in patients with renal insufficiency.

Because of considerable overlap of risk factors and a myriad of pathophysiologic mechanisms, insufficiencies of the renal and cardiac system are tightly related.2 Furthermore, when . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure
Roy S. Gardner, Kwok S. Chong, Eileen O’Meara, Alan Jardine, Ian Ford, and Theresa A. McDonagh
EHJ 2007 28: 3027-3033. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Eur J Heart FailHome page
U. Alehagen, U. Dahlstrom, and T. L. Lindahl
Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care
Eur J Heart Fail, April 1, 2009; 11(4): 354 - 360.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
R. Tagore, L. H. Ling, H. Yang, H.-Y. Daw, Y.-H. Chan, and S. K. Sethi
Natriuretic Peptides in Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1644 - 1651.
[Abstract] [Full Text] [PDF]